Yes, an 8-hour fast is recommended before amyloid blood-based biomarker testing.
The majority of Alzheimer's disease studies globally utilize fasting blood collection, with an 8-hour fast being the standard recommendation 1. This guideline comes from the international working group on standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease.
Key Recommendations
Fasting Requirements
- At least 8 hours since last meal is recommended for blood-based amyloid testing 1
- Whether fasting or non-fasting procedures are used, the time since last meal should be documented 1
- This standardization is critical because fasting duration has a known impact on many blood-based biomarker levels 1
Why This Matters
The 8-hour fasting requirement exists for several important reasons:
- Standardization across studies: The majority of ongoing Alzheimer's disease cohort studies utilize fasting blood collection, though many fail to articulate the specific fasting duration 1
- Preanalytic variability: Approximately 46% of errors in laboratory testing come from the preanalytic phase, including factors like food and beverage consumption prior to collection 1
- Biomarker accuracy: Patient-related factors including food and beverages consumed prior to collection can significantly impact blood marker results 1
Additional Best Practices
When collecting blood for amyloid testing, the guidelines also recommend:
- Morning collection (before 10am) to address possible diurnal fluctuations in biomarker levels 1
- 21-gauge needle is preferable 1
- Total processing time ≤2 hours from stick-to-freezer 1
Important Caveat
While the 8-hour fast is the standard recommendation for research and clinical validation of blood-based amyloid biomarkers, some major studies (TARCC, ADCS, NIA Best Practices, Alzheimer Center Amsterdam) do not require fasting blood draws 1. However, given that the majority of studies globally use fasting protocols and this represents the consensus recommendation for standardization, fasting should be followed in clinical practice to ensure optimal accuracy and comparability of results.